DadFinStart your free week
DadFin › Stocks › Consumer Defensive › NUS

Nu Skin Enterprises, Inc. (NUS) stock score

Consumer Defensive · Household & Personal Products · United States

$4.74 ▼ -0.63% today

69.5
Dad Score, out of 100
middling

Nu Skin Enterprises, Inc. (NUS) is a Household & Personal Products company in the Consumer Defensive sector, listed in the United States. On DadFin's weekly run it scores 69.5 out of 100 on the Dad Score, a middling reading that places the business ahead of 69% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Consumer Defensive it ranks #64 of 232. Its strongest axes are valuation, quality and price action; its weakest are growth and conviction.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Strong
Quality
Strong
Growth
Weak
Price action
Above average
Risk
Above average
Conviction
Weak
Liquidity
Weak
Macro
Weak

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)4.0×
Dividend yield5.27%
Return on capital18.4%
Operating margin6.1%
Revenue growth (YoY)-14.3%
FCF yield21.9%
Net debt / EBITDA0.80×
Piotroski F-Score7 / 9
52-week change-58.3%
Market cap$224M
Next earningsNov 5, 2026

What subscribers see on NUS

Start your free weekSubscriber? Open the full research →

Household & Personal Products peers

StockCompanyDad ScoreBandMarket cap
PGThe Procter & Gamble Company46.1middling$336.8B
ULUnilever PLC34.5weak$128.6B
CLColgate-Palmolive Company26.7weak$67.2B
ELThe Estée Lauder Companies Inc.53.8middling$33.3B
KVUEKenvue Inc.53.1middling$33.0B
KMBKimberly-Clark Corporation21.9weak$31.3B
CHDChurch & Dwight Co., Inc.59.6middling$22.4B
CLXThe Clorox Company8.9poor$9.7B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.